Monday, September 16, 2024

Vaxcyte’s stock dips after biotech completes $1.42 billion stock offering

Must read




Vaxcyte Inc.’s stock fell 3% early Friday, after the company completed a stock offering that is expected to generate $1.42 billion in proceeds.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article